Skip to main content

Detail

Erika Jensen-Jarolim
Prof. Erika Jensen-Jarolim, MDHead of Comparative Medicine, interuniversity Messerli Research Institute

Center for Pathophysiology, Infectiology and Immunology (Institute of Pathophysiology and Allergy Research)
Position: Professor

T +43 1 40400 51100
erika.jensen-jarolim@meduniwien.ac.at

Further Information

Keywords

Allergy and Immunology; Allergy Diagnosis; Clinical Immunology; Dermatology; Oncology; Vaccinology

Research group(s)

  • MD
  • Prof. Jensen-Jarolim

Research interests

Prof. Erika Jensen-Jarolim, MD, immunologist, is appointed to the interuniversity Messerli Research Institut, Vienna, Austria. Her academic research is dedicated to immunological mechanisms underlying hypersensitivity or tolerance to antigens, and to improve therapy of allergy. In daily patient care she practices molecular allergy diagnosis.

Grants

  • IgE/IgG targeting of cancer antigens ErbB-1 & ErbB-2 in dog (2011)
    Source of Funding: FWF (Austrian Science Fund), Stand-Alone Projects
    Principal Investigator
  • Towards prevention and therapy of allergy (project part leader) (2011)
    Source of Funding: FWF (Austrian Science Fund), Special Research Programmes (SFB46)
    Principal Investigator

Selected publications

  1. Jensen-Jarolim, E. et al., 2015. Structural similarities of human & mammalian lipocalins, and their function in innate immunity and allergy. Allergy. 2015 Oct 23. doi: 10.1111/all.12797. [Epub ahead of print] Available at: http://www.ncbi.nlm.nih.gov/pubmed/26497994.
  2. Stremnitzer, C. et al., 2015. Papain Degrades Tight Junction Proteins of Human Keratinocytes In Vitro and Sensitizes C57BL/6 Mice via the Skin Independent of its Enzymatic Activity or TLR4 Activation. Journal of Investigative Dermatology, 135(7), pp.1790-1800. Available at: http://dx.doi.org/10.1038/jid.2015.58.
  3. Roth-Walter, F. et al., 2014. Bet v 1 from Birch Pollen Is a Lipocalin-like Protein Acting as Allergen Only When Devoid of Iron by Promoting Th2 Lymphocytes. J. Biol. Chem., 289(25), pp.17416-17421. Available at: http://dx.doi.org/10.1074/jbc.M114.567875.
  4. Stremnitzer, C. et al., 2014. Epicutaneously applied Der p 2 induces a strong T H 2-biased antibody response in C57BL/6 mice, independent of functional TLR4 . Allergy, 69(6), pp.741-751. Available at: http://dx.doi.org/10.1111/all.12399.
  5. Jensen-Jarolim, E. et al., 2008. AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy. 2008 Oct; 63(10):1255-66. doi: 10.1111/j.1398-9995.2008.01768.x. Epub 2008 Jul 26. Available at: http://www.ncbi.nlm.nih.gov/pubmed/1867177.